| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.23683 |
| P8608 | Fatcat ID | release_ofxrvyv3sbg6rh5i7bdypoyhym |
| P698 | PubMed publication ID | 20683955 |
| P5875 | ResearchGate publication ID | 45495292 |
| P50 | author | Gideon M. Hirschfield | Q37829929 |
| P2093 | author name string | Teru Kumagi | |
| Catalina Coltescu | |||
| Nadya Al-Harthy | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis | Q34427089 | ||
| Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients | Q34462959 | ||
| Quality of life and everyday activities in patients with primary biliary cirrhosis | Q35142961 | ||
| Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. | Q35596429 | ||
| Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort | Q35760389 | ||
| Fatigue complicating chronic liver disease | Q35956377 | ||
| The true impact of fatigue in primary biliary cirrhosis: a population study | Q40643274 | ||
| Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up | Q43239506 | ||
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
| The demography of primary biliary cirrhosis in Ontario, Canada | Q44439436 | ||
| Quality of life in patients with primary biliary cirrhosis | Q45059665 | ||
| Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis | Q46408092 | ||
| Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis | Q46436991 | ||
| A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis | Q48444812 | ||
| Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence | Q48496394 | ||
| Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. | Q50945983 | ||
| Fatigue is not a specific symptom in patients with primary biliary cirrhosis. | Q51933023 | ||
| Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. | Q52920374 | ||
| Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. | Q53190185 | ||
| Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. | Q53300236 | ||
| Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. | Q53527400 | ||
| Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. | Q53778988 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity | Q57710875 | ||
| Chronic cholestasis in rats induces anhedonia and a loss of social interest | Q74764234 | ||
| Fatigue in primary biliary cirrhosis | Q77586211 | ||
| Fatigue in primary biliary cirrhosis: a possible role of comorbidities | Q80477655 | ||
| Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance | Q80687728 | ||
| Fatigue in patients with primary sclerosing cholangitis | Q80928489 | ||
| TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice | Q82068670 | ||
| Serum anti-mitochondrial antibodies and fatigue in primary biliary cirrhosis | Q84425062 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 562-570 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice | |
| P478 | volume | 52 |
| Q52346107 | 'It's as if PBC didn't exist': the illness experience of women affected by primary biliary cirrhosis. |
| Q100467658 | A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis |
| Q48331749 | Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. |
| Q61451434 | Gulf War Illness: Unifying Hypothesis for a Continuing Health Problem |
| Q43725734 | Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study |
| Q37355843 | Natural history and management of primary biliary cirrhosis |
| Q36786270 | Nuclear receptors as drug targets in cholestatic liver diseases |
| Q56428272 | Primary biliary cirrhosis |
| Q57141930 | Primary biliary cirrhosis |
| Q26853145 | Primary biliary cirrhosis and liver transplantation |
| Q26853649 | Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy |
| Q56442936 | Primary sclerosing cholangitis |
| Q48060155 | Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis |
| Q54976907 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. |
| Q35589931 | The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis |
| Q36418947 | The impact of osteoporosis on health-related quality of life in patients after liver transplantation - a pilot study |
| Q36754953 | The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms |
| Q38659201 | Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients |
Search more.